Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 2
- Cultivation
Releaf and Glass Pharms to Offer THCV Range Aimed at Weight Management
UK medical cannabis cultivator Glass Pharms has partnered with leading clinic Releaf to bring cannabis containing meaningful levels of THCV (Tetrahydrocannabivarin), a cannabinoid linked to reduced appetite in emerging research, to patients in the UK for the first time since 1973.
- Medical Cannabis
Spain’s Medical Cannabis Framework Finally Reaches Patients, But Rollout is ‘Not the Finish Line’
Spain’s medical cannabis framework will finally start reaching patients over the coming days and weeks, marking a significant milestone in a four-year battle for access.
- Clinical Research
Helius Therapeutics to Supply New Phase 2 Cannabis Sleep Trial
Helius Therapeutics has today announced a supply agreement with the University of Auckland for a new Phase 2 trial into cannabis as a sleep aid for patients which chronic back pain.
- Hemp Industry
As the EU Moves to Protect Hemp, Ireland Still Treats It as a Drug
The criminalisation of industrial hemp and CBD flower across European nations has, sadly, only continued to spread since we published our last edition of ‘Hemp Wars’ in May.
- Data & Analysis
UK vs Germany – Medical Cannabis Products & Prices (2026 Update)
Over the last decade, the European medical cannabis landscape has seen a significant surge of new products entering the market, providing patients, especially in the UK and Germany, with a greater variety than ever before.
- Medical Cannabis
France’s Final Medical Cannabis Decree Could Be Complete in the ‘Coming Weeks’
Frances’ incoming medical cannabis framework is expected to take the final step before it can be signed into law in the ‘coming weeks’.
- Hemp Industry
Hemp Could Be the UK’s Overlooked Net Zero Solution, New Report Argues
The UK’s Cannabis Industry Council (CIC) has launched a new report calling for industrial hemp regulation to be transferred from the Home Office to the Department for Environment, Food and Rural Affairs (DEFRA), arguing that the current licensing regime is holding back a crop capable of helping the UK meet its binding Net Zero commitments.
- M&A Activity
The Aurora Ménage à Trois: Three Shifts in Seven Days
Curaleaf Holdings’ battle to acquire Aurora Cannabis has shifted in favour of the Canadian producer on multiple fronts over the last week.
- Medical Cannabis
‘Unacceptable Failure of Duty of Care’: Bedrocan Bankruptcy Leaves Life-Saving Medicine Frozen in Storage
Bedrocan’s Dutch entities have officially been declared bankrupt, leaving stocks of life-saving medicinal cannabis in the hands of court-appointed administrators who cannot release them.
- Investment & Finance
Europe Now a Growth Priority for North American Cannabis Capital
North American institutional cannabis investors now see the European medical market as a crucial driver of growth, a new survey suggests.
- Cultivation
Dutch Cannabis Patients Facing 10-Month Supply Gap, Many With ‘No Therapeutic Alternative’
Thousands of Dutch patients are facing a 10-month supply gap for medically essential Bedrocan products, including varieties clinicians consider irreplaceable for children with treatment-resistant epilepsy.
- Medical Cannabis
Germany to Soften Cannabis Insurance Reforms as Exilby Lobbying Row Escalates
Germany’s coalition government has retreated further on its controversial medical cannabis reimbursement reforms as it faces mounting questions over how and why the law came to be.
